Jodi Devlin - 24 Nov 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Signature
/s/ Mary Szela, Attorney-in-Fact
Issuer symbol
TLSI
Transactions as of
24 Nov 2025
Transactions value $
$0
Form type
4
Filing time
25 Nov 2025, 15:56:02 UTC
Previous filing
21 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Devlin Jodi Chief of Clinical Operations 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 25 Nov 2025 0001992151

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +50K +98.87% $0.00 101K 24 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +100K +27.49% $0.00 464K 24 Nov 2025 Common Stock 100K $5.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date.